Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
š¼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Seegene Inc (096530 KS)
Watchlist
103
Analysis
Health Care
ā¢
South Korea
Seegene, Inc. manufactures In Vitro Diagnostic (IVD) products mainly through molecular diagnostic method. The Company provides diagnostic & screening products for cancer, sepsis, influenza and virus infection.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
ā¢
SK Bioscience
ā¢
27 Nov 2021 06:44
The Highly Mutated Omicron COVID Variant - Onset of the Dark Winter?
There has been a new, highly mutated COVID variant found in South Africa named Omicron by the WHO. In this insight, we will provide further details...
Douglas Kim
Follow
774 Views
Share
bullish
ā¢
Kumho Petro Chemical
ā¢
22 Nov 2021 15:17
Yearend Dividend-Hunt Buying Vs. Majority Shareholder Transfer Tax-Triggered Selling
This post looks at the yearend dividend-hunt buying versus the ā©1B majority shareholder transfer tax-triggered selling trend.
Sanghyun Park
Follow
464 Views
Share
bullish
ā¢
Kumho Petro Chemical
ā¢
16 Nov 2021 16:02
Potential Yearend Short-Covering Stocks in Korea
In Korea's local stock market, intense short-covering at the yearend dividend season has been consistently observed since mid-November. So, this...
Sanghyun Park
Follow
524 Views
Share
bullish
ā¢
Seegene Inc
ā¢
21 Oct 2021 23:05
Seegene (096530 KS): Worst Seems to Be Over; Non-COVID Revenue to Dictate Long-Term Growth
Seegene is expected to see COVID testing revenue recovery in H2, driven by surging delta variants in Europe and some Asian countries. Non-COVID...
Tina Banerjee
Follow
504 Views
Share
bullish
ā¢
Krafton
ā¢
31 Aug 2021 17:21
KRX BBIG Index Rebalance: Krafton, SK Bioscience, SK IE Tech Included (Among Others)
Krafton has been added to the Game index, SK IE Tech added to the Battery index, SK Bioscience to the Bio index. Lots of flow on some names....
Brian Freitas
Follow
382 Views
Share
First
Previous
8
9
10
11
12
13
14
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright Ā© 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x